Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor

Anticancer Res. 1998 Jul-Aug;18(4B):2827-32.

Abstract

Background: We investigated the utility of clinical FDG-PET in patients with nasopharyngeal tumor treated by radiotherapy, retrospectively.

Materials and methods: Fifteen patients with known or suspected nasopharyngeal tumors underwent FDG-PET. PET images were evaluated with visual interpretation qualitatively. Semiquantitative analysis was also performed on the metabolic ratios (MRs).

Results: The sensitivity and specificity of FDG-PET based on visual inspection were 92.9% (13/14) and 83.3% (10/12), respectively. There was a statistically significant difference between histological types in the mean MR. MR was significantly decreased by radiotherapy in patients with poorly differentiated squamous cell carcinoma. PET scans obtained 1-3 months after radiotherapy indicated decreased levels of FDG uptake in all tumors but one scan did not accurately reflect the status of the disease.

Conclusion: These results are encouraging as to the clinical usefulness of FDG-PET for evaluating radiation effects in patients with nasopharyngeal tumor.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / diagnostic imaging*
  • Nasopharyngeal Neoplasms / radiotherapy
  • Radiopharmaceuticals*
  • Sensitivity and Specificity
  • Tomography, Emission-Computed
  • Tomography, X-Ray Computed

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18